WuXi Biologics (Cayman) Inc. (SEHK: 2269)
Health Care · Life Sciences Tools & Services · CN
HK$53.85
-0.46% today · +31.5% 1Y
WuXi Biologics (Cayman) Inc. (SEHK: 2269) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $28.16B and employs 14,705 people.
Over the last twelve months the share price has gained 31.5%, trading between 28.48 and 58.00.
Tweenvest scores WuXi Biologics (Cayman) Inc. across four factors: quality 74/100, value 39/100, growth 90/100. Its strongest factor is growth.
2269 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $28.16B
- Revenue (TTM)
- $3.48B
- P/E
- 39.38
- EPS
- 1.18
- Dividend yield
- —
- Beta (5Y)
- 0.59
- 52-week high
- HK$58.00
- 52-week low
- HK$28.48
- Avg volume (3M)
- —
- Shares outstanding
- 4.10B
- Employees
- 14,705
- Next earnings
- —
About WuXi Biologics (Cayman) Inc.
Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman) Inc. delivers a comprehensive, integrated suite of services spanning the entire biologics lifecycle, from initial discovery through development to large-scale manufacturing. The company's operations have a global footprint, serving clients across the People's Republic of China, North America, Europe, and other international regions. Its diversified offerings also include specialized consultation in biopharmaceutical technology, international sales contracting, the development and deployment of advanced testing methodologies, and robust marketing and sales support. Furthermore, WuXi Biologics is involved in providing dedicated biologics clinical and manufacturing services, the production and distribution of various medical products, contract development and manufacturing (CDMO) for vaccines and associated businesses, and acting as a supplier of key materials. The firm maintains strategic partnerships with notable entities such as ImmuneOncia Therapeutics, Legochem Biosciences Inc., Worg Pharma, OncoC4, and Exelixis Inc.
- ISIN
- KYG970081173
- Founded
- 2014
- Listed since
- Jun 13, 2017
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Waters CorporationNYSE: WAT | $42.62B | $430.59 | -0.73% |
| Illumina, Inc.NasdaqGS: ILMN | $42.00B | $272.66 | -1.98% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $41.93B | ₩1,219,000.00 | -9.97% |
| Mettler-Toledo International Inc.NYSE: MTD | $31.06B | $1,560.21 | +0.66% |
| West Pharmaceutical Services, Inc.NYSE: WST | $25.76B | $370.09 | +1.12% |
| Divi's Laboratories LimitedNSEI: DIVISLAB | $25.62B | Rs9,340.00 | +0.98% |
| Sartorius Stedim Biotech S.A.ENXTPA: DIM | $23.18B | €214.20 | +0.66% |
| Sartorius AktiengesellschaftXTRA: SRT3 | $17.70B | €254.30 | +0.51% |
Figures last refreshed Oct 11, 2026.